A nationwide epidemiologic study in France examined a correlation between Guillain-Barré syndrome and recent bone or digestive organ surgery.
High-dose intravenous immunoglobulin therapy was administered to all patients and may have contributed to neutralization of eculizumab.
Rheumatological disorders were associated with a 7-fold risk of developing Guillain-Barré syndrome.
Infection with the Zika virus may increase the risk for development of Guillain-Barré syndrome.
Patients with cancer or an autoimmune disease who underwent surgery were at a greater risk.
Anti-GalC IgG may contribute to the pathogenesis of Guillain-Barré syndrome.
The CDC recently confirmed the link between Zika virus and microcephaly.
It's unclear whether the effect that the vaccine has on contracting influenza is responsible for the reduced risk.
Neurology Advisor Articles
- Guidance for Antibiotic Use in Myasthenia Gravis
- Lorcaserin May Reduce Motor Seizures in Pediatric Treatment-Resistant Epilepsy
- FDA Warns of Rare Stroke Risk With Multiple Sclerosis Drug
- Rituximab Effects in Neuromyelitis Optica Spectrum Disorders
- Myoclonic-Atonic Seizures and Lennox-Gastaut Syndrome Present With Overlapping Features, Difficulty in Diagnosis
- Migraine With Aura Linked to Increase in Incident A-Fib
- TBI Increases Dementia Risk in Middle-Age and Elderly Patients With T1D
- NIHSS May Misjudge Infratentorial Lesions in Thrombolysis-Eligible Stroke
- Study Identifies Area Postrema Syndrome Identification Criteria in NMOSD
- Neurofilament Light Biomarkers Identify Alzheimer Disease Risk in Down Syndrome